DiscoverOncology On The GoS2 Ep11: Between the Lines: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer
S2 Ep11: Between the Lines: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer

S2 Ep11: Between the Lines: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer

Update: 2021-10-19
Share

Description

As part of CancerNetwork’s Between the Lines video series, Brian Helfand, MD, PhD, Chief of the Division of Urology and the Ronald L. Chez Family and Richard Melman Family Endowed Chair at NorthShore University HealthSystem, and Steven Finkelstein, MD, FACRO, a radiation oncologist with Florida Cancer Affiliates US Oncology Network in Panama City, Florida, examined the results and clinical implications of the phase 2/3 EMPIRE-1 trial in prostate cancer. The trial compares 18F-fluciclovine PET/CT imaging versus conventional imaging to guide postprostatectomy salvage radiotherapy.




To watch more videos in CancerNetwork’s Between the Lines series, visit cancernetwork.com.
Comments 
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
S2 Ep26: Between the Lines Podcast: Tazemetostat in Relapsed/Refractory Follicular Lymphoma

S2 Ep26: Between the Lines Podcast: Tazemetostat in Relapsed/Refractory Follicular Lymphoma

2022-11-0321:10

S2 Ep25: Between the Lines™ Podcast: Updates in Use of Proteasome Inhibitors for Relapsed/Refractory Multiple Myeloma

S2 Ep25: Between the Lines™ Podcast: Updates in Use of Proteasome Inhibitors for Relapsed/Refractory Multiple Myeloma

2022-05-2022:24

S2 Ep24: OncView™ Podcast: Advances in Systemic Therapy of Differentiated Thyroid Cancer

S2 Ep24: OncView™ Podcast: Advances in Systemic Therapy of Differentiated Thyroid Cancer

2022-05-0634:36

S2 Ep23: OncView™ Podcast: Safety and Efficacy of Available Treatment Options and Considerations for Patient Management in Metastatic RCC

S2 Ep23: OncView™ Podcast: Safety and Efficacy of Available Treatment Options and Considerations for Patient Management in Metastatic RCC

2022-04-2930:07

S2 Ep22: Between the Lines™ Podcast: Mobocertinib Use in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive mNSCLC

S2 Ep22: Between the Lines™ Podcast: Mobocertinib Use in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive mNSCLC

2022-04-2727:37

S2 Ep21: OncView™ Podcast: EGFR Exon 20 Insertion as Therapeutic Target in NSCLC

S2 Ep21: OncView™ Podcast: EGFR Exon 20 Insertion as Therapeutic Target in NSCLC

2022-04-0821:01

S2 Ep20: Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer

S2 Ep20: Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer

2022-04-0525:24

S2 Ep19: OncView™ Podcast: Immunotherapy Response Monitoring in Melanoma

S2 Ep19: OncView™ Podcast: Immunotherapy Response Monitoring in Melanoma

2022-04-0243:51

S2 Ep18: OncView™ Podcast: Immunotherapy Response Monitoring in Lung Cancer

S2 Ep18: OncView™ Podcast: Immunotherapy Response Monitoring in Lung Cancer

2022-03-3018:12

S2 Ep17: Between the Lines™ Podcast: Incorporating Real-World Evidence into Clinical Decisions in NSCLC

S2 Ep17: Between the Lines™ Podcast: Incorporating Real-World Evidence into Clinical Decisions in NSCLC

2022-01-1441:45

S2 Ep16: Future Directions in Small Cell Lung Cancer Treatment

S2 Ep16: Future Directions in Small Cell Lung Cancer Treatment

2021-12-2207:44

S2 Ep15: Practical Considerations for Small Cell Lung Cancer Therapeutic Options

S2 Ep15: Practical Considerations for Small Cell Lung Cancer Therapeutic Options

2021-12-1613:21

S2 Ep14: Treatment Options for Relapsed/Refractory Small Cell Lung Cancer

S2 Ep14: Treatment Options for Relapsed/Refractory Small Cell Lung Cancer

2021-12-0213:38

S2 Ep13: First-Line Therapeutic Options in Small Cell Lung Cancer

S2 Ep13: First-Line Therapeutic Options in Small Cell Lung Cancer

2021-11-0110:08

S2 Ep12: OncView™ Podcast: Connie Batlevi, MD, PhD on R/R Follicular Lymphoma Therapy Updates

S2 Ep12: OncView™ Podcast: Connie Batlevi, MD, PhD on R/R Follicular Lymphoma Therapy Updates

2021-10-2925:10

S2 Ep11: Between the Lines: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer

S2 Ep11: Between the Lines: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer

2021-10-1936:20

S2 Ep10: Two Experts Review Important R/R DLBCL Treatment Decisions and Data

S2 Ep10: Two Experts Review Important R/R DLBCL Treatment Decisions and Data

2021-08-3018:13

S2 Ep9: OncView™ Podcast: Updates in Therapies of Relapsed/Refractory Follicular Lymphoma

S2 Ep9: OncView™ Podcast: Updates in Therapies of Relapsed/Refractory Follicular Lymphoma

2021-08-2520:09

S2 Ep8: OncView™ Podcast: NCCN Guideline Updates in HR+ Breast Cancer

S2 Ep8: OncView™ Podcast: NCCN Guideline Updates in HR+ Breast Cancer

2021-08-2023:22

S2 Ep7: Kami Maddocks, MD, on Rituximab Rechallenging and Second-Line Therapies for R/R DLBCL

S2 Ep7: Kami Maddocks, MD, on Rituximab Rechallenging and Second-Line Therapies for R/R DLBCL

2021-07-3014:25

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

S2 Ep11: Between the Lines: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer

S2 Ep11: Between the Lines: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer

CancerNetwork